{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:45:17Z","timestamp":1792507517326,"version":"4.5.0"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"vor","delay-in-days":80,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.jtauto.2021.100098","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T20:30:31Z","timestamp":1616790631000},"page":"100098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Lymphomagenesis predictors and related pathogenesis"],"prefix":"10.1016","volume":"4","author":[{"given":"Ingrid","family":"Ruiz-Ordo\u00f1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Manuel","family":"Piedrahita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier-Andr\u00e9s","family":"Ar\u00e9valo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Agualimpia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6031-4218","authenticated-orcid":false,"given":"Gabriel J.","family":"Tob\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2021.100098_bib1","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis","volume":"74","author":"Qin","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2021.100098_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2018.00102","article-title":"Lymphoma and lymphomagenesis in primary Sj\u00f6gren\u2019s syndrome","volume":"5","author":"Alunno","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.jtauto.2021.100098_bib3","first-page":"450","article-title":"Rate, risk factors and causes of mortality in patients with sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis of cohort studies","volume":"55","author":"Singh","year":"2016","journal-title":"Rheumatol. (United Kingdom)."},{"key":"10.1016\/j.jtauto.2021.100098_bib4","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","article-title":"Increased risk of lymphoma in sicca syndrome","volume":"89","author":"Kassan","year":"1978","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jtauto.2021.100098_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.jtauto.2021.100098_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0156376","article-title":"Scoping review of the Zika virus literature","volume":"11","author":"Waddell","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jtauto.2021.100098_bib7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nrrheum.2011.62","article-title":"Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma","volume":"7","author":"Dias","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jtauto.2021.100098_bib8","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2741\/2219","article-title":"Role of B cells in Sjogren\u2019s syndrome--from benign lymphoproliferation to overt malignancy","volume":"12","author":"Jonsson","year":"2007","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jtauto.2021.100098_bib9","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0046-8177(88)80259-4","article-title":"Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis","volume":"19","author":"Hyjek","year":"1988","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jtauto.2021.100098_bib10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S1079-2104(05)80307-5","article-title":"Immunoglobulin gene rearrangements in lymphoplasmacytic infiltrates of labial salivary glands in Sjogren\u2019s syndrome. A possible predictor of lymphoma development","volume":"79","author":"Jordan","year":"1995","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.jtauto.2021.100098_bib11","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/0961203319857132","article-title":"Prognostic markers of lymphoma development in primary Sjogren syndrome","volume":"28","author":"Retamozo","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.jtauto.2021.100098_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00296-019-04470-x","article-title":"Clonal relationship of marginal zone lymphoma and diffuse large B-cell lymphoma in Sjogren\u2019s syndrome patients: case series study and review of the literature","volume":"40","author":"Gorodetskiy","year":"2020","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jtauto.2021.100098_bib13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/art.1780400217","article-title":"Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjogren\u2019s syndrome","volume":"40","author":"De Vita","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2021.100098_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaut.2012.05.014","article-title":"B\u00a0cells in Sj\u00f6gren\u2019s syndrome: from pathophysiology to diagnosis and treatment","volume":"39","author":"Cornec","year":"2012","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jtauto.2021.100098_bib15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2249.1990.tb05481.x","article-title":"Monoclonal process in primary Sj\u00f6gren\u2019s syndrome and cross-reactive idiotype associated with rheumatoid factor","volume":"82","author":"Katsikis","year":"1990","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtauto.2021.100098_bib16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4049\/jimmunol.136.2.477","article-title":"Expression of a cross-reactive idiotype on rheumatoid factor in patients with Sjogren\u2019s syndrome","volume":"136","author":"Fox","year":"1986","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jtauto.2021.100098_bib17","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3390\/cells8111365","article-title":"Germinal centre B cell functions and lymphomagenesis: circuits involving MYC and MicroRNAs","volume":"8","author":"Robaina","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jtauto.2021.100098_bib18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nri3814","article-title":"Germinal centres and B cell lymphomagenesis","volume":"15","author":"Basso","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jtauto.2021.100098_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3722","article-title":"Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy","volume":"15","author":"Czabotar","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jtauto.2021.100098_bib20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.autrev.2018.02.003","article-title":"Cytokine markers of B lymphocytes in minor salivary gland infiltrates in Sjogren\u2019s syndrome","volume":"17","author":"Navarro-Mendoza","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2021.100098_bib21","first-page":"102656","article-title":"Molecular pathogenesis of MALT lymphoma","author":"Troppan","year":"2015","journal-title":"Gastroenterol. Res. Pract. 2015"},{"key":"10.1016\/j.jtauto.2021.100098_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1573395511309010003","article-title":"Possible mechanisms of lymphoma development in Sj\u00f6gren\u2019s syndrome","volume":"9","author":"Dong","year":"2013","journal-title":"Curr. Immunol. Rev."},{"key":"10.1016\/j.jtauto.2021.100098_bib23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12308-017-0302-2","article-title":"Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma","volume":"10","author":"Schreuder","year":"2017","journal-title":"J.\u00a0Hematop"},{"key":"10.1016\/j.jtauto.2021.100098_bib24","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/eji.1830260715","article-title":"Flt3 ligand supports the differentiation of early B cell progenitors in the presence of interleukin-11 and interleukin-7","volume":"26","author":"Ray","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jtauto.2021.100098_bib25","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/bjh.15578","article-title":"Direct role of FLT3 in regulation of early lymphoid progenitors","volume":"183","author":"Zriwil","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jtauto.2021.100098_bib26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2006-09-047480","article-title":"Crucial role of FLT3 ligand in immune reconstitution after bone marrow transplantation and high-dose chemotherapy","volume":"110","author":"Buza-Vidas","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtauto.2021.100098_bib27","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1002\/art.38129","article-title":"Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjogren\u2019s syndrome","volume":"65","author":"Tob\u00f3n","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2021.100098_bib28","series-title":"Cell. Mol. Immunol.","first-page":"251","article-title":"B\u00a0cell activation and antibody production","author":"Abbas","year":"2018"},{"key":"10.1016\/j.jtauto.2021.100098_bib29","first-page":"133","volume":"14","author":"Nocturne","year":"2018","journal-title":"B\u00a0cells in the pathogenesis of primary Sj\u00f6gren syndrome"},{"key":"10.1016\/j.jtauto.2021.100098_bib30","first-page":"4","volume":"39","author":"Tzioufas","year":"2012","journal-title":"Pathogenesis of Sj\u00f6gren\u2019s syndrome: What we know and what we should learn"},{"key":"10.1016\/j.jtauto.2021.100098_bib31","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1586\/1744666X.2014.891439","article-title":"B-cell hyperactivity in primary Sj\u00f6gren\u2019s syndrome","volume":"10","author":"Kroese","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jtauto.2021.100098_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jaut.2010.06.012","article-title":"Activation of the type I interferon pathway in primary Sjogren\u2019s syndrome","volume":"35","author":"Mavragani","year":"2010","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jtauto.2021.100098_bib33","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/rheumatology\/kem079","article-title":"Predicting adverse outcomes in primary Sjogren\u2019s syndrome: identification of prognostic factors","volume":"46","author":"Brito-Zer\u00f3n","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2021.100098_bib34","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","article-title":"Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren\u2019s syndrome","volume":"46","author":"Ioannidis","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2021.100098_bib35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0049-0172(98)80040-1","article-title":"Predictors of lymphoma development in primary Sjogren\u2019s syndrome","volume":"28","author":"Sutcliffe","year":"1998","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2021.100098_bib36","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","article-title":"Lymphoma and other malignancies in primary Sjogren\u2019s syndrome: a cohort study on cancer incidence and lymphoma predictors","volume":"65","author":"Theander","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2021.100098_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00296-014-3051-x","article-title":"Identification of lymphoma predictors in patients with primary Sj\u00f6gren\u2019s syndrome: a systematic literature review and meta-analysis","volume":"35","author":"Nishishinya","year":"2015","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jtauto.2021.100098_bib38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaut.2013.10.002","article-title":"Biomarkers of lymphoma in Sj\u00f6gren\u2019s syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study","volume":"51","author":"Quartuccio","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jtauto.2021.100098_bib39","article-title":"Predicting the risk for lymphoma development in Sjogren syndrome","volume":"95","author":"Fragkioudaki","year":"2016","journal-title":"Med. (United States)."},{"key":"10.1016\/j.jtauto.2021.100098_bib40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jaut.2015.07.002","article-title":"Type I and II interferon signatures in Sjogren\u2019s syndrome pathogenesis: contributions in distinct clinical phenotypes and Sjogren\u2019s related lymphomagenesis","volume":"63","author":"Nezos","year":"2015","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jtauto.2021.100098_bib41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1089\/jir.2018.0087","article-title":"The interferon-gamma paradox in cancer","volume":"39","author":"Zaidi","year":"2019","journal-title":"J.\u00a0Interf. Cytokine Res. Off. J. Int. Soc. Interf. Cytokine Res."},{"key":"10.1016\/j.jtauto.2021.100098_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar1912","article-title":"B\u00a0cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sj\u00f6gren\u2019s syndrome","volume":"8","author":"Ittah","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2021.100098_bib43","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/rheumatology\/kes180","article-title":"BLyS upregulation in Sjogren\u2019s syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands","volume":"52","author":"Quartuccio","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2021.100098_bib44","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/354389a0","article-title":"Intraclonal generation of antibody mutants in germinal centres","volume":"354","author":"Jacob","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.jtauto.2021.100098_bib45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri2217","article-title":"Germinal centres: role in B-cell physiology and malignancy","volume":"8","author":"Klein","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jtauto.2021.100098_bib46","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM199911113412007","article-title":"Cellular origin of human B-cell lymphomas","volume":"341","author":"K\u00fcppers","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jtauto.2021.100098_bib47","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/ard.2010.144782","article-title":"Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren\u2019s syndrome","volume":"70","author":"Theander","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2021.100098_bib48","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/art.40528","article-title":"Ectopic germinal center-like structures in minor salivary gland biopsy tissue predict lymphoma occurrence in patients with primary sjogren\u2019s syndrome","volume":"70","author":"Sene","year":"2018","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)."},{"key":"10.1016\/j.jtauto.2021.100098_bib49","first-page":"171","article-title":"Germinal Centers in Diagnostic Biopsies of Patients With Primary Sjogren\u2019s Syndrome Are Not a Risk Factor for Non-Hodgkin\u2019s Lymphoma but a Reflection of High Disease Activity: comment on the Article by Sene et al","volume":"71","author":"Sene","year":"2019","journal-title":"ARTHRITIS Rheumatol"},{"key":"10.1016\/j.jtauto.2021.100098_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2019.00471","article-title":"CXCL13 and its receptor CXCR5 in cancer: inflammation, immune response, and beyond","volume":"10","author":"Kazanietz","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jtauto.2021.100098_bib51","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/bjh.12941","article-title":"Follicular helper T-cells: expanding roles in T-cell lymphoma and targets for treatment","volume":"166","author":"Ahearne","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jtauto.2021.100098_bib52","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","article-title":"Follicular helper T cells","volume":"34","author":"Vinuesa","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jtauto.2021.100098_bib53","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1084\/jem.20091777","article-title":"IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism","volume":"207","author":"Zotos","year":"2010","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jtauto.2021.100098_bib54","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1084\/jem.20091738","article-title":"IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses","volume":"207","author":"Linterman","year":"2010","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jtauto.2021.100098_bib55","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/leu.2011.301","article-title":"Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells","volume":"26","author":"Am\u00e9-Thomas","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jtauto.2021.100098_bib56","first-page":"I156","article-title":"Lymphoid chemokines CXCL13 and CCL21 are abnormaly upregulated in salivary glands of malt lymphomas in Sjogren\u2019s syndrome and associate with the histological organisation of the reactive and malignant components of the lymphoid proliferation","volume":"45","author":"Barone","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2021.100098_bib57","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1002\/art.39315","article-title":"CXCL13 and CCL11 serum levels and lymphoma and disease activity in primary sjogren\u2019s syndrome","volume":"67","author":"Nocturne","year":"2015","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)."},{"key":"10.1016\/j.jtauto.2021.100098_bib58","doi-asserted-by":"crossref","first-page":"102690","DOI":"10.1016\/j.autrev.2020.102690","article-title":"Minor salivary gland biopsy: its role in the classification and prognosis of Sj\u00f6gren\u2019s syndrome","volume":"19","author":"Bautista-Vargas","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2021.100098_bib59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2009.06.008","article-title":"Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity","volume":"31","author":"Colonna","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jtauto.2021.100098_bib60","doi-asserted-by":"crossref","first-page":"11024","DOI":"10.1073\/pnas.1503315112","article-title":"IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs","volume":"112","author":"Barone","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jtauto.2021.100098_bib61","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ni.2025","article-title":"Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22","volume":"12","author":"Sonnenberg","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jtauto.2021.100098_bib62","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/ijms20030649","article-title":"Interleukin-18 in health and disease","volume":"20","author":"Yasuda","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtauto.2021.100098_bib63","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.0105-2896.2004.00214.x","article-title":"IL-12 and IL-23: master regulators of innate and adaptive immunity","volume":"202","author":"Langrish","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jtauto.2021.100098_bib64","doi-asserted-by":"crossref","first-page":"109388","DOI":"10.1016\/j.cellsig.2019.109388","article-title":"IL-18\/IL-18BP and IL-22\/IL-22BP: two interrelated couples with therapeutic potential","volume":"63","author":"M\u00fchl","year":"2019","journal-title":"Cell. Signal."},{"key":"10.1016\/j.jtauto.2021.100098_bib65","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1002\/art.23073","article-title":"Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sj\u00f6gren\u2019s syndrome: correlation with certain features of immune hyperactivity and factors associated with h","volume":"56","author":"Manoussakis","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2021.100098_bib66","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/cei.12643","article-title":"Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren\u2019s syndrome and Sjogren-associated non-Hodgkin lymphomas and is regulated by IL-18","volume":"181","author":"Ciccia","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtauto.2021.100098_bib67","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.joms.2017.05.021","article-title":"Minor salivary gland biopsy\u2014an important contributor to the diagnosis of sj\u00f6gren syndrome","volume":"75","author":"Wicheta","year":"2017","journal-title":"J.\u00a0Oral Maxillofac. Surg."},{"key":"10.1016\/j.jtauto.2021.100098_bib68","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1136\/annrheumdis-2013-204634","article-title":"The prognostic value of routinely performed minor salivary gland assessments in primary Sj\u00f6gren\u2019s syndrome","volume":"73","author":"Risselada","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2021.100098_bib69","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/modpathol.2016.92","article-title":"Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine","volume":"29","author":"Sun","year":"2016","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jtauto.2021.100098_bib70","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2559.2010.03699.x","article-title":"MALT lymphoma: many roads lead to nuclear factor-\u03bab activation","volume":"58","author":"Du","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.jtauto.2021.100098_bib71","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.blre.2016.10.001","article-title":"NF-\u03baB signaling pathway and its potential as a target for therapy in lymphoid neoplasms","volume":"31","author":"Yu","year":"2017","journal-title":"Blood Rev."},{"key":"10.1016\/j.jtauto.2021.100098_bib72","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1182\/blood-2013-05-503383","article-title":"Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sj\u00f6gren\u2019s syndrome","volume":"122","author":"Nocturne","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtauto.2021.100098_bib73","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/ng.2779","article-title":"A\u00a0genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sj\u00f6gren\u2019s syndrome at 7q11.23","volume":"45","author":"Li","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jtauto.2021.100098_bib74","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ng.2792","article-title":"Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sj\u00f6gren\u2019s syndrome","volume":"45","author":"Lessard","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jtauto.2021.100098_bib75","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jaut.2013.04.005","article-title":"B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren\u2019s syndrome","volume":"51","author":"Nezos","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jtauto.2021.100098_bib76","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1002\/art.39231","article-title":"A\u00a0BAFF receptor His159Tyr mutation in Sjogren\u2019s syndrome-related lymphoproliferation","volume":"67","author":"Papageorgiou","year":"2015","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)."},{"key":"10.1016\/j.jtauto.2021.100098_bib77","first-page":"480","article-title":"Germinal centers and autoantibodies, Immunol","volume":"98","author":"Young","year":"2020","journal-title":"Cell Biol."},{"key":"10.1016\/j.jtauto.2021.100098_bib78","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1365-2362.2010.02342.x","article-title":"Autoimmune response and target autoantigens in Sjogren\u2019s syndrome","volume":"40","author":"Routsias","year":"2010","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.jtauto.2021.100098_bib79","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.berh.2007.09.001","article-title":"Update on Sjogren\u2019s syndrome autoimmune epithelitis: from classification to increased neoplasias","volume":"21","author":"Tzioufas","year":"2007","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.jtauto.2021.100098_bib80","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.semarthrit.2013.04.004","article-title":"Malignant lymphoma in primary Sjogren\u2019s syndrome: an update on the pathogenesis and treatment","volume":"43","author":"Routsias","year":"2013","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2021.100098_bib81","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/bjh.13192","article-title":"Sjogren Syndrome-associated lymphomas: an update on pathogenesis and management","volume":"168","author":"Nocturne","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jtauto.2021.100098_bib82","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/ard.60.11.1007","article-title":"Lymphomas complicating Sj\u00f6gren\u2019s syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells","volume":"60","author":"Mariette","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2021.100098_bib83","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0049-0172(96)80019-9","article-title":"Clinicopathological factors relating malignant lymphoma with Sjogren\u2019s syndrome","volume":"25","author":"Anaya","year":"1996","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2021.100098_bib84","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/rheumatology\/kew194","article-title":"Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sjogren syndrome: analysis of 515 patients","volume":"55","author":"Retamozo","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2021.100098_bib85","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/rheumatology\/ket427","article-title":"Primary Sjogren\u2019s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients","volume":"53","author":"Baldini","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2021.100098_bib86","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/art.1780390508","article-title":"Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjogren\u2019s syndrome","volume":"39","author":"Tzioufas","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2021.100098_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2016.00036","article-title":"Early components of the complement classical activation pathway in human systemic autoimmune diseases","volume":"7","author":"Lintner","year":"2016","journal-title":"Front. Immunol."},{"issue":"Suppl 1","key":"10.1016\/j.jtauto.2021.100098_bib88","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/odi.13041","article-title":"World Workshop on Oral Medicine VII: biomarkers predicting lymphoma in the salivary glands of patients with Sjogren\u2019s syndrome-A systematic review","volume":"25","author":"Delli","year":"2019","journal-title":"Oral Dis."},{"key":"10.1016\/j.jtauto.2021.100098_bib89","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/art.20176","article-title":"Mortality and causes of death in primary Sjogren\u2019s syndrome - a prospective cohort study","volume":"50","author":"Theander","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2021.100098_bib90","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MD.0b013e3181b76ab5","article-title":"Hematologic manifestations and predictors of lymphoma development in primary Sjogren syndrome: clinical and pathophysiologic aspects","volume":"88","author":"Baimpa","year":"2009","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jtauto.2021.100098_bib91","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3899\/jrheum.110754","article-title":"A\u00a0clinical prediction rule for lymphoma development in primary Sjogren\u2019s syndrome","volume":"39","author":"Baldini","year":"2012","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jtauto.2021.100098_bib92","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.semarthrit.2011.04.006","article-title":"Risk, predictors, and clinical characteristics of lymphoma development in primary sj\u00f6gren\u2019s syndrome","volume":"41","author":"Solans-Laqu\u00e9","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2021.100098_bib93","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/ard.60.5.467","article-title":"A\u00a0longitudinal cohort study of Finnish patients with primary Sjogren\u2019s syndrome: clinical, immunological, and epidemiological aspects","volume":"60","author":"Pertovaara","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2021.100098_bib94","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.semarthrit.2013.03.001","article-title":"Clinical features distinguishing lymphoma development in primary Sj\u00f6gren\u2019s syndrome-A retrospective cohort study","volume":"43","author":"Risselada","year":"2013","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2021.100098_bib95","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1073\/pnas.69.7.1697","article-title":"2 -Microglobulin--a free immunoglobulin domain","volume":"69","author":"Peterson","year":"1972","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jtauto.2021.100098_bib96","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5045\/br.2014.49.3.148","article-title":"Serum beta-2 microglobulin in malignant lymphomas: an old but powerful prognostic factor","volume":"49","author":"Yoo","year":"2014","journal-title":"Blood Res."},{"key":"10.1016\/j.jtauto.2021.100098_bib97","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.drudis.2008.11.001","article-title":"Beta2-microglobulin: emerging as a promising cancer therapeutic target","volume":"14","author":"Shi","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jtauto.2021.100098_bib98","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/1744666X.2019.1649596","article-title":"Predicting lymphoma development in patients with Sj\u00f6gren\u2019s syndrome","volume":"15","author":"De Vita","year":"2019","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.jtauto.2021.100098_bib99","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/rheumatology\/38.3.245","article-title":"Primary Sjogren\u2019s syndrome in the North East of England: a long-term follow-up study","volume":"38","author":"Davidson","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2021.100098_bib100","first-page":"S150","article-title":"The evaluation of disease activity in Sj\u00f6gren\u2019s syndrome based on the degree of MALT involvement: glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort study","volume":"36","author":"De Vita","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jtauto.2021.100098_bib101","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1006\/bcmd.2001.0446","article-title":"Preliminary classification of nonmalignant B cell proliferation in Sjogren\u2019s syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach","volume":"27","author":"De Vita","year":"2001","journal-title":"Blood Cells. Mol. Dis."},{"key":"10.1016\/j.jtauto.2021.100098_bib102","first-page":"S150","article-title":"The evaluation of disease activity in Sj\u00f6gren\u2019s syndrome based on the degree of MALT involvement: glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort study","volume":"36","author":"De Vita","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jtauto.2021.100098_bib103","doi-asserted-by":"crossref","first-page":"102316","DOI":"10.1016\/j.jaut.2019.102316","article-title":"Predictive markers of lymphomagenesis in Sj\u00f6gren\u2019s syndrome: from clinical data to molecular stratification","volume":"104","author":"Kapsogeorgou","year":"2019","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jtauto.2021.100098_bib104","first-page":"296","article-title":"Clinical evolution, and morbidity and mortality of primary","volume":"5","author":"Skopouli","year":"2000","journal-title":"Sj\u00f6gren\u2019s Syndrome"},{"key":"10.1016\/j.jtauto.2021.100098_bib105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MD.0b013e31820fd2d1","article-title":"Peripheral neuropathies associated with primary sj\u00f6gren syndrome: immunologic profiles of nonataxic sensory neuropathy and sensorimotor neuropathy","volume":"90","author":"S\u00e8ne","year":"2011","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jtauto.2021.100098_bib106","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/brain\/awh605","article-title":"The wide spectrum of clinical manifestations in Sj\u00f6gren\u2019s syndrome-associated neuropathy","volume":"128","author":"Mori","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jtauto.2021.100098_bib107","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/art.23102","article-title":"Diagnostic and prognostic relevance of neuromuscular biopsy in primary Sjogren\u2019s syndrome-related neuropathy","volume":"57","author":"Terrier","year":"2007","journal-title":"ARTHRITIS Rheum. CARE Res."},{"key":"10.1016\/j.jtauto.2021.100098_bib108","article-title":"ESSDAI): a user guide","volume":"1","author":"Seror","year":"2015","journal-title":"RMD Open"},{"key":"10.1016\/j.jtauto.2021.100098_bib109","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.18632\/oncotarget.3052","article-title":"The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy","volume":"6","author":"Humphries","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtauto.2021.100098_bib110","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/toxsci\/kfr029","article-title":"Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b","volume":"121","author":"Wang","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jtauto.2021.100098_bib111","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/annrheumdis-2017-212639","article-title":"Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjogren\u2019s syndrome","volume":"77","author":"Kapsogeorgou","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2021.100098_bib112","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/joim.12115","article-title":"The P2X7 receptor-inflammasome complex has a role in modulating the inflammatory response in primary Sj\u00f6gren\u2019s syndrome","volume":"274","author":"Baldini","year":"2013","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.jtauto.2021.100098_bib113","first-page":"20","volume":"vol. 223","author":"Arend","year":"2008"},{"key":"10.1016\/j.jtauto.2021.100098_bib114","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1002\/art.21969","article-title":"Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sj\u00f6gren\u2019s syndrome","volume":"54","author":"Ek","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2021.100098_bib115","doi-asserted-by":"crossref","first-page":"R447","DOI":"10.1186\/ar1209","article-title":"Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sj\u00f6gren\u2019s syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate","volume":"6","author":"Bombardieri","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2021.100098_bib116","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/joim.12631","article-title":"The P2X7 receptor\u2013NLRP3 inflammasome complex predicts the development of non-Hodgkin\u2019s lymphoma in Sjogren\u2019s syndrome: a prospective, observational, single-centre study","volume":"282","author":"Baldini","year":"2017","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.jtauto.2021.100098_bib117","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1084\/jem.192.5.671","article-title":"Molecular cloning and biological characterization of a novel murine lymphoid growth factor","volume":"192","author":"Sims","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jtauto.2021.100098_bib118","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ni.1852","article-title":"Sensing the outside world: TSLP regulates barrier immunity","volume":"11","author":"Ziegler","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jtauto.2021.100098_bib119","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/ni1360","article-title":"Thymic stromal lymphopoietin in normal and pathogenic T cell development and function","volume":"7","author":"Ziegler","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jtauto.2021.100098_bib120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2020.01557","article-title":"Modulation of signaling mediated by TSLP and IL-7 in inflammation, autoimmune diseases, and cancer","volume":"11","author":"Markovi\u0107","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2021.100098_bib121","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/s41590-019-0524-9","article-title":"TSLP: from allergy to cancer","volume":"20","author":"Corren","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jtauto.2021.100098_bib122","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/annrheumdis-2020-eular.3689","article-title":"Thymic stromal lymphopoietin (TSLP) as a biomarker of primary Sjogren\u2019s Syndrome (pSS) and related lymphoma: validation in independent cohorts","volume":"79","author":"Gandolfo","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2021.100098_bib123","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/jir.2016.0086","article-title":"Immune diseases associated with TREX1 and STING dysfunction","volume":"37","author":"Yan","year":"2017","journal-title":"J.\u00a0Interf. Cytokine Res. Off. J. Int. Soc. Interf. Cytokine Res."},{"key":"10.1016\/j.jtauto.2021.100098_bib124","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2007.10.017","article-title":"Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease","volume":"131","author":"Yang","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jtauto.2021.100098_bib125","series-title":"Genetics, TREX 1 Mutations","author":"Hosseini","year":"2020"},{"key":"10.1016\/j.jtauto.2021.100098_bib126","first-page":"154781","volume":"132","author":"Nezos","year":"2020","journal-title":"TREX1 variants in Sjogren\u2019s syndrome related lymphomagenesis"},{"key":"10.1016\/j.jtauto.2021.100098_bib127","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1741-7015-10-87","article-title":"The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem?","volume":"10","author":"Diamandis","year":"2012","journal-title":"BMC Med."},{"key":"10.1016\/j.jtauto.2021.100098_bib128","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/art.1780360309","article-title":"Preliminary criteria for the classification of Sj\u00f6gren\u2019s syndrome. Results of a prospective concerted action supported by the European community","volume":"36","author":"Vitali","year":"1993","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2021.100098_bib129","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/art.1780290501","article-title":"Sj\u00f6gren\u2019s syndrome. Proposed criteria for classification","volume":"29","author":"Fox","year":"1986","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jtauto.2021.100098_bib130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/15027732.1986.12461371","article-title":"The Copenhagen criteria for Sj\u00f6gren\u2019s syndrome","volume":"61","author":"Manthorpe","year":"1986","journal-title":"Scand. J. Rheumatol. Suppl."},{"key":"10.1016\/j.jtauto.2021.100098_bib131","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2021.100098_bib132","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/rheumatology\/kep404","article-title":"Incidence of malignancy in primary Sj\u00f6gren\u2019s syndrome in a Chinese cohort","volume":"49","author":"Zhang","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2021.100098_bib133","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3899\/jrheum.090835","article-title":"Clinical and prognostic significance of parotid scintigraphy in 405 patients with primary sjogren\u2019s syndrome","volume":"37","author":"Ramos-Casals","year":"2010","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jtauto.2021.100098_bib134","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00296-012-2464-7","article-title":"Primary Sjogren\u2019s syndrome and B-non-Hodgkin lymphoma: role of CD4+ T lymphocytopenia","volume":"33","author":"Ismail","year":"2013","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jtauto.2021.100098_bib135","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/acr.21887","article-title":"Risk of non-Hodgkin\u2019s lymphoma in primary Sjogren\u2019s syndrome: a population-based study","volume":"65","author":"Johnsen","year":"2013","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jtauto.2021.100098_bib136","first-page":"157","article-title":"A\u00a0retrospective study of long-term outcomes in 152 patients with primary Sj\u00f6gren\u2019s syndrome: 25-Year experience","volume":"14","author":"Abrol","year":"2014","journal-title":"Clin. Med. J. R. Coll. Physicians London."},{"key":"10.1016\/j.jtauto.2021.100098_bib137","first-page":"1","article-title":"Characterization and risk estimate of cancer in patients with primary Sjogren syndrome","volume":"10","author":"Brito-Zeron","year":"2017","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.jtauto.2021.100098_bib138","doi-asserted-by":"crossref","first-page":"50098","DOI":"10.18632\/oncotarget.15100","article-title":"Predictable biomarkers of developing lymphoma in patients with Sj\u00f6gren syndrome: a nationwide population-based cohort study","volume":"8","author":"Chiu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtauto.2021.100098_bib139","first-page":"69","article-title":"Development of lymphoma in patients with sjogren\u2019s syndrome","volume":"14","author":"Schenone","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jtauto.2021.100098_bib140","first-page":"35","volume":"vol. 69","author":"Shiboski","year":"2016-2017"},{"key":"10.1016\/j.jtauto.2021.100098_bib141","first-page":"541","article-title":"U.K. primary Sjogren\u2019s syndrome registry","volume":"40","author":"Traianos","year":"2020","journal-title":"Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sj\u00f6gren\u2019s syndrome"}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909021000186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909021000186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:43:11Z","timestamp":1762904591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909021000186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":141,"alternative-id":["S2589909021000186"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2021.100098","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphomagenesis predictors and related pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2021.100098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100098"}}